NEKTAR THERAPEUTICS
NKTR·640268108·UQ·Common Stock·Healthcare - Biotechnology-13D/G
NKTR (NEKTAR THERAPEUTICS) is held by 122 institutional investors as of Q2 2026. Largest holders: FMR LLC ($353.8M), BlackRock, Inc. ($205.4M), VANGUARD CAPITAL MANAGEMENT LLC ($104.5M). Net institutional sentiment: Bullish.
122
Holders
(6 Elite)
$1.4B
Total Value
72% (131)
Consensus
94 buying - 37 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Sep 25, 2026 · Activists Nov 14, 2025 · Congress none
InsiderWAWHITFIELD ROY AVest 2K shSep 23, 2026
InsiderBDBrainard DianaVest 2K shSep 23, 2026
InsiderCRCHESS ROBERTVest 2K shSep 23, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 138
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer